Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma.
about
Liver fluke induces cholangiocarcinomaA granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cellsOpisthorchis viverrini: the carcinogenic human liver flukeCancer biomarker discovery for cholangiocarcinoma: the high-throughput approachesIntrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapiesGenetic profiling of intrahepatic cholangiocarcinomaCrucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agentsOutlook on Thailand's genomics and computational biology research and development.Cholangiocarcinoma: lessons from ThailandRoles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion.Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinomaCholangiocarcinoma: new insights into disease pathogenesis and biology.Inflammatory cytokines suppress arylamine N-acetyltransferase 1 in cholangiocarcinoma cellsGenetic and environmental determinants of risk for cholangiocarcinoma in Thailand.Differential activation of diverse glutathione transferases of Clonorchis sinensis in response to the host bile and oxidative stressors.Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome.Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.A novel predictive equation for potential diagnosis of cholangiocarcinoma.Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humansQuinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.Analysis of whole genomic expression profiles and screening of the key signaling pathways associated with pancreatic cancerKnockdown of TMEM45A inhibits the proliferation, migration and invasion of glioma cells.Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma.Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.Establishment of an allo-transplantable hamster cholangiocarcinoma cell line and its application for in vivo screening of anti-cancer drugs.Cholangiocarcinoma--controversies and challenges.Expression of the sulfotransferase 1C family: implications for xenobiotic toxicity.Genomic and transcriptional alterations of cholangiocarcinoma.Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinomaTGF-β Signaling in Gastrointestinal Cancers: Progress in Basic and Clinical Research.Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma.Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells.Synergistic effects of isomorellin and forbesione with doxorubicin on apoptosis induction in human cholangiocarcinoma cell lines.Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinomaThe construction of intrahepatic cholangiocarcinoma model in zebrafishImmunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine.Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis.Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma.New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis.
P2860
Q21092372-23892A0B-ABCF-4675-B032-B8AF7D9607F0Q21131573-F2A92A8D-8AF6-4963-8DAD-BB689F59F444Q24658412-8BD4DB65-A94E-406D-95AA-5B316F3A7EADQ26821926-6308C016-573C-4ADC-8A65-29713E7186C3Q27002547-380588AD-6B6F-475F-884A-43C2103544ACQ27005787-EF524C6F-22F2-4EAC-95F0-040E6BB3B7D9Q28482275-09BE9D34-1312-4FE5-8CE8-8280B50550CDQ30397955-A5D7E5EA-E826-4701-B880-097FEC28E876Q34034208-944F8656-99FD-497C-A7FA-A91B75C1FDCAQ34099141-7EE0220F-A488-46CB-9DAE-54F20325022AQ34102283-5594830B-A3EE-4864-AA06-E37CA3C7D228Q34194655-B89FA7AF-05E3-4A68-A452-056616D962D0Q34225242-70B963AD-C088-402C-8B6E-14015541DB05Q34508893-525051F7-C452-494F-8620-52589CF5E16EQ34734252-48B382E2-6300-4C2B-B463-B09DE70E253BQ34909875-F80E9D67-7286-4305-8495-4B3FE4D20AAEQ34978321-ADFC9312-8BAB-48BF-97EB-2A1510D27A65Q35107080-EB524E26-4EDE-4D31-AE30-FC96CA2FC37BQ35249205-0473C7A8-0B82-44E8-9970-52B9724506F7Q35410253-453DD436-5A01-4B75-9264-3B8A610C204DQ36196775-B629CFE2-82D2-4E02-A37E-F3AEF1B508DFQ36375193-0CD0FB18-053E-4784-A1DC-1A456591C719Q36414244-717BBD07-2DC0-42F0-B5E8-5FF182EEAC27Q36759538-BD44D841-4D98-4825-A448-C2A7A5227575Q37563199-A8D3AE66-AB06-4AF5-94B0-7A7F40D00EADQ37860916-F90F633A-37D9-401A-9FC8-3D1C5AD8F3C7Q38136704-B2E7BEB3-A6D7-46C4-B8BB-F4A7AA8E0A3DQ38188515-9303F780-462C-447B-89D5-259046431088Q38740975-6D76B7B2-B212-4F57-BE45-718938367788Q39096525-E2E214DE-06B0-4E87-BC17-34FE2476D4BFQ39312152-CB898AA4-EA77-4BA0-8C2F-6187979F6A0DQ39491891-E3B6ABE3-FA1A-4015-9D5C-1194AE422D85Q39498232-0770A743-FF10-4356-92D2-0F2ED7B97F53Q39562830-2D71674C-5E49-484F-A068-24E2D0D3EFAFQ42683890-C328D97D-56EB-4C20-8247-707E41595FBAQ44109455-28027FA1-9FEA-4CEB-8B34-BD74563C6B49Q44602053-F5978C8D-5AC1-47AA-B92A-D88F5B611C1BQ47955863-77F6EE25-A5C4-41EE-98F3-760B6D3BD47EQ50050635-A503F73E-1E66-40A6-B254-00FFE76EF516Q54209730-995CFAA5-F707-4E38-AEE1-00A1DFA0246D
P2860
Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Comparison of gene expression ...... trahepatic cholangiocarcinoma.
@ast
Comparison of gene expression ...... trahepatic cholangiocarcinoma.
@en
Comparison of gene expression ...... trahepatic cholangiocarcinoma.
@nl
type
label
Comparison of gene expression ...... trahepatic cholangiocarcinoma.
@ast
Comparison of gene expression ...... trahepatic cholangiocarcinoma.
@en
Comparison of gene expression ...... trahepatic cholangiocarcinoma.
@nl
prefLabel
Comparison of gene expression ...... trahepatic cholangiocarcinoma.
@ast
Comparison of gene expression ...... trahepatic cholangiocarcinoma.
@en
Comparison of gene expression ...... trahepatic cholangiocarcinoma.
@nl
P2093
P356
P1433
P1476
Comparison of gene expression ...... trahepatic cholangiocarcinoma.
@en
P2093
Chawalit Pairojkul
Kazutaka Obama
Natini Jinawath
Tatsuhiko Tsunoda
Yaovalux Chamgramol
Yoichi Furukawa
Yusuke Nakamura
P2860
P304
P356
10.1002/HEP.21330
P407
P577
2006-10-01T00:00:00Z